Adage Capital Management, L.P. - 30 Sep 2025 SCHEDULE 13G Report for Bright Minds Biosciences Inc. Common Shares, no par value (DRUG)

Filing Manager
Adage Capital Management, L.P.
Reporting Manager
Adage Capital Management, L.P.
Security
Bright Minds Biosciences Inc. Common Shares, no par value
Symbol
DRUG
Shares outstanding
7,092,168 shares
Disclosed Ownership
395,743 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
13 Nov 2025, 09:00:15 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Adage Capital Management, L.P. 5.6% 395,743 0 395,743 /s/ Robert Atchinson By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Robert Atchinson 5.6% 395,743 0 395,743 /s/ Robert Atchinson Robert Atchinson, individually
Phillip Gross 5.6% 395,743 0 395,743 /s/ Phillip Gross Phillip Gross, individually